NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, in partnership with KCSA Strategic Communications (“KCSA”), today announced the agenda for the upcoming KCSA Psychedelics Virtual Investor Conference to be held on April 27-28, 2022. Individual investors, institutional investors, advisors, and analysts are invited to attend this two-day virtual event showcasing live company presentations and interactive discussions focused on psychedelic treatments for mental health disorders.

“As we have seen over the past 18 months, drug development is hard. The good news is many of the companies presenting over the two-day event have shown tremendous clinical progress. I would encourage investors to take a traditional pharma or biotech view of this space and practice patience, do the proper diligence, and the rewards will be tremendous,” said Lewis Goldberg, Managing Partner and Founder of KCSA’s Psychedelics Practice. “Drug development for mental health care takes time, focus, and is capital intensive. The potential returns remain as dramatic as ever, it’s the investors who – to steal a line from Michael Pollan – need to change their minds.”

REGISTER NOW AT: https://bit.ly/3rFbSuZ

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend live presentations and schedule 1x1 meetings.

April 27th Agenda:

Eastern
Time (ET)		PresentationTicker(s)
9:30 AMHMNC Brain HealthPrivate
10:00 AMField Trip Health Ltd.NASDAQ: FTRP | TSX: FTRP
10:30 AMPsyched Wellness Ltd.OTCQB: PSYCF | CSE: PSYC
11:00 AMEnveric BiosciencesNASDAQ: ENVB
11:30 AMLobe Sciences Ltd.OTCQB: LOBEF | CSE: LOBE
12:00 PMNinnion TherapeuticsPrivate
12:30 PMPsyBio TherapeuticsOTCQB: PSYBF | TSXV: PSYB
1:00 PMNuminus WellnessOTCQX: NUMIF | TSX: NUMI

April 28th Agenda:

Eastern
Time (ET)		PresentationTicker(s)
9:30 AMSmall Pharma Inc.OTCQB: DMTTF | TSXV: DMT
10:00 AMMindset Pharma Inc.OTCQB: MSSTF | CSE: MSET
10:30 AMGilgamesh PharmaPrivate
11:00 AMCybin Inc.NYSE AMEX: CYBN | NEO: CYBN
11:30 AMFilament Health Corp.OTCQB: FLHLF | NEO: FH
12:00 PMAwaken Life Sciences Corp.OTCQB: AWKNF | NEO: AWKN

To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.

About Virtual Investor Conferences®

Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

About KCSA Strategic Communications

KCSA is a fully integrated communications agency specializing in public relations, investor relations and social media, with expertise in financial and professional services, technology, healthcare, digital media and cannabis. Since 1969, the firm has demonstrated strategic thinking and program execution that drives results for its clients in the ever-changing communications and digital landscape. The firm's clients are its best references. For more information, please visit www.kcsa.com.

Media Contact: 
OTC Markets Group Inc. +1 (212) 896-4428, media@otcmarkets.com

Virtual Investor Conferences Contact:
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com

KCSA Contact:
Allison Soss / Tim Regan
KCSA Strategic Communications
conference@kcsa.com


Primary Logo

Source: Virtual Investor Conferences

2022 GlobeNewswire, Inc., source Press Releases